Skip to main content

Table 2 Vaccine coverage and reasons for non-vaccination of Latin American patients*

From: Influenza and pneumococcal vaccination coverage in Latin American patients with systemic lupus erythematosus: a cross-sectional and comparative study

 

Argentina

(265)

Mexico

(214)

Brazil

(190)

Chile

(99)

Peru

(96)

Colombia

(63)

Uruguay

(59)

All patients

(1130)

Influenza

178 (67.2)

38 (17.8)

114 (60)

51 (51.5)

21 (21.9)

15 (23.8)

19 (32.2)

482 (42.7)

Pneumococcal

146 (55.1)

23 (10.7)

41 (21.6)

14 (14.1)

9 (9.4)

8 (12.7)

14 (23.7)

282 (25)

Influenza and pneumococcal

128 (48.3)

11 (5.1)

35 (18.4)

10 (10.1)

6 (6.3)

5 (7.9)

9 (15.3)

222 (19.6)

Tetanus

129 (48.7)

61 (28.5)

87 (45.8)

9 (9.1)

21 (21.9)

18 (28.6)

50 (84.7)

424 (37.5)

No influenza and no pneumococcal

69 (26)

164 (76.6)

70 (36.8)

44 (44.4)

72 (75)

45 (71.4)

35 (59.3)

588 (52)

Incomplete vaccinationa

194 (73.2)

205 (95.8)

165 (86.8)

96 (97)

93 (96.9)

61 (96.8)

53 (89.8)

998 (88.3)

Lack of medical prescription b

126 (64.9)

135 (63.1)

104 (63)

73 (76)

65 (69.9)

48 (78.7)

27 (50.9)

645 (64.6)

Rejection by patients b

26 (13.4)

29 (14.1)

15 (9.1)

9 (9.4)

16 (17.2)

1 (1.6)

15 (28.3)

127 (12.7)

Not available/ cost issues b

18 (9.3)

13 (6.3)

21 (12.7)

9 (9.4)

12 (12.9)

5 (8.2)

1 (1.9)

113 (11.3)

Others b

28 (14.4)

36 (17.6)

31 (18.8)

13 (13.5)

7 (7.5)

9 (14.8)

10 (18.9)

164 (16.4)

  1. * Except where indicated otherwise, values are the number (%) of patients
  2. aIncludes those who reported not having received at least one of the vaccines (influenza, pneumonia or tetanus)
  3. bThe percentage was calculated using the number of non-vaccinated as the denominator